Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02818413 · ClinicalTrials.gov registry record
Stool Microbiome, Pathogens, and Infectious Agents Among Olympic and Elite Athletes
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 32
- Enrollment target
NCT02818413: Completed study, sponsored by Mayo Clinic.
NCT02818413 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02818413 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This research is being done to investigate fecal microbiome and metabolome as well as serum analytes and single nucleotide polymorphisms in Olympic athletes in comparison with other elite athletes.
Interventions
- OTHER Biospecimen collection and questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-06-03 |
| Est. Completion | 2017-03-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02818413
The ClinicalTrials.gov registry entry for NCT02818413 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biospecimen collection and questionnaires is the first listed.
NCT02818413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02818413 about?
NCT02818413 is a clinical study titled "Stool Microbiome, Pathogens, and Infectious Agents Among Olympic and Elite Athletes". This research is being done to investigate fecal microbiome and metabolome as well as serum analytes and single nucleotide polymorphisms in Olympic athletes in comparison with other elite athletes.
What is the current status of trial NCT02818413?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2016-06-03. Estimated completion is 2017-03-21.
What interventions are being tested in trial NCT02818413?
The interventions under investigation include: Biospecimen collection and questionnaires (OTHER).
Who is sponsoring clinical trial NCT02818413?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.